StockWatch
·
Major Chemicals
Quarterly ResultJul 29, 2026, 04:47 PM

FMC Q2 Revenue $867M, Adj. EBITDA $153M; Lowers FY26 Outlook

AI Summary

FMC Corporation reported Q2 2026 revenue of $867 million, a 17% decrease year-over-year, with Adjusted EBITDA of $153 million, down 26%, but above the high end of guidance. Adjusted EPS declined 62% to $0.26. The company lowered its full-year 2026 outlook for revenue, Adjusted EBITDA, and Adjusted EPS, citing a challenging macro environment. FMC also announced strategic actions, including the sale of its India business and a licensing agreement, aiming to generate approximately $1 billion for debt reduction.

Key Highlights

  • Q2 2026 revenue was $867 million, a 17% decrease from Q2 2025.
  • Q2 2026 Adjusted EBITDA was $153 million, down 26% year-over-year, but above guidance.
  • Q2 2026 Adjusted EPS was $0.26, a 62% decline from Q2 2025.
  • Full-year 2026 revenue outlook lowered to $3.50 billion to $3.70 billion.
  • Full-year 2026 Adjusted EBITDA outlook lowered to $620 million to $680 million.
  • Full-year 2026 Adjusted EPS outlook lowered to $1.19 to $1.49.
  • Q2 GAAP cash from operations was $363 million, up $297 million, including a $200 million licensing payment.
  • Company expects to generate approximately $1 billion from asset sales and equity investment for debt reduction.